Хайлтын үр дүнгүүд - Mecide Gharibo

  • 5-н 1 - 5 үр дүнгүүдийг харуулж байна
Үр дүнг сайжруулах
  1. 1
    A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD–56-positive Multiple Myeloma

    A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD–56-positive Multiple Myel... -н Sikander Ailawadhi, Kevin R. Kelly, Robert Vescio, Sundar Jagannath, Jeffrey Wolf, Mecide Gharibo, Taimur Sher, Leyla Bojanini, Maurice Kirby, Asher Chanan‐Khan

    Хэвлэсэн 2018
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma

    A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma -н Jamie Cavenagh, Heather Oakervee, P Baetiong-Caguioa, Faith E. Davies, Mecide Gharibo, Neil Rabin, Michael R. Kurman, Barbara Novak, Norihiko Shiraishi, Daisuke Nakashima, Shiro Akinaga, Kwee Yong

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell Therapies

    Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving... -н Sarah Nikiforow, Matthew J. Frigault, Noelle V. Frey, Rebecca Gardner, Krishna V. Komanduri, Miguel‐Angel Perales, Partow Kebriaei, Phyllis I. Warkentin, Marcelo C. Pasquini, Joy Lynn Aho, Bruce L. Levine, Helen E. Heslop, Tracey L. Hlucky, Karen Habucky, Mecide Gharibo, Madan Jagasia, Frederick L. Locke

    Хэвлэсэн 2023
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier

    Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier -н Cecilia Carpio, Réda Bouabdallah, Loïc Ysebaert, Juan‐Manuel Sancho, Gilles Salles, Raúl Córdoba, Antonio Pinto, Mecide Gharibo, Drew Rasco, Carlos Panizo, José A. López-Martín, Armando Santoro, Antonio Salar, Silvia Damian, Alejandro Martı́n, Gregor Verhoef, Éric Van Den Neste, Maria Wang, Suzana S. Couto, Soraya Carrancio, Andrew P. Weng, Xuehai Wang, Frank Schmitz, Xin Wei, Kristen Hege, Matthew Trotter, Alberto Risueño, Tonia J. Buchholz, Patrick R. Hagner, Anita K. Gandhi, Michael Pourdehnad, Vincent Ribrag

    Хэвлэсэн 2020
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

    Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial -н Sagar Lonial, Brendan M. Weiss, Saad Z. Usmani, Seema Singhal, Ajai Chari, Nizar J. Bahlis, Andrew R. Belch, Amrita Krishnan, Robert Vescio, María‐Victoria Mateos, Amitabha Mazumder, Robert Z. Orlowski, Heather J. Sutherland, Joan Bladé, Emma C. Scott, Albert Oriol, Jesús G. Berdeja, Mecide Gharibo, Don A. Stevens, Richard LeBlanc, Michaël Sébag, Natalie S. Callander, Andrzej Jakubowiak, Darrell White, Javier de la Rubia, Paul G. Richardson, Steen Lisby, Huaibao Feng, Clarissa Uhlar, Imran Khan, Tahamtan Ahmadi, Peter M. Voorhees

    Хэвлэсэн 2016
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: